A multidisciplinary approach to the management of disorders of gut-brain interaction: psychopharmacology, psychotherapy, and diet
Frontiers in Gastroenterology · 07.10.2025 · 4
DOI: 10.3389/fgstr.2025.1637172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Gastroenterology, online erschienen am 07.10.2025. Verfasst von Francisco J Barrera Flores und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Introduction
Disorders of gut-brain interaction (DGBI), including irritable bowel syndrome and functional dyspepsia, are chronic gastrointestinal syndromes characterized by visceral hypersensitivity and altered brain-gut signaling in the absence of known structural pathology. A significant proportion of individuals with DGBI have comorbid psychiatric conditions, especially anxiety and depression, highlighting the biopsychosocial underpinnings of these disorders.
Methods
This narrative review synthesizes the neurophysiological, psychological, pharmacological, and psychotherapeutic literature related to DGBI. We examined the role of gut-brain axis dysregulation, the prevalence and impact of psychiatric comorbidity, and evaluated current treatment modalities, including neuromodulators, brain-gut behavior therapies (BGBTs), and dietary interventions.
Results
Neuroimaging and genetic studies support the role of emotional and cognitive circuits in modulating gut sensitivity and symptom perception. Psychiatric comorbidity, particularly anxiety, is bidirectionally linked to DGBI and influences treatment response. Neuromodulators such as tricyclic antidepressants demonstrate modest efficacy. BGBTs—including cognitive behavioral therapy and gut-directed hypnotherapy—exhibit comparable efficacy to pharmacologic treatments, with sustained symptom relief and additional benefit on mood and illness-related beliefs.
Discussion
DGBI represent complex, stress-sensitive conditions best managed through multidisciplinary care. Integration of pharmacologic neuromodulation, psychotherapeutic interventions, and dietary strategies targeting the brain-gut axis offers the most comprehensive approach. Future research should refine treatment matching based on symptom phenotype, psychological profile, and gut-brain biomarkers to improve long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
- Department of Psychiatry, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.
- Department of Nutrition, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Förderung
- NIDDK NIH HHS
- NIMH NIH HHS
Zitieren
APA
Barrera Flores, F. J., Tamez, J. A. G., Winkelman, T., Flores, R. B., & Madva, E. N. (2025). A multidisciplinary approach to the management of disorders of gut-brain interaction: psychopharmacology, psychotherapy, and diet. Frontiers in Gastroenterology, 4. https://doi.org/10.3389/fgstr.2025.1637172
Vancouver
Barrera Flores FJ, Tamez JAG, Winkelman T, Flores RB, Madva EN. A multidisciplinary approach to the management of disorders of gut-brain interaction: psychopharmacology, psychotherapy, and diet. Frontiers in Gastroenterology. 2025;4. doi:10.3389/fgstr.2025.1637172
BibTeX
@article{BarreraFlores2025,
author = {Barrera Flores, Francisco J and Tamez, José Adrián Guerrero and Winkelman, Tatiana and Flores, Regina Barrera and Madva, Elizabeth N},
title = {A multidisciplinary approach to the management of disorders of gut-brain interaction: psychopharmacology, psychotherapy, and diet},
journal = {Frontiers in Gastroenterology},
year = {2025},
volume = {4},
doi = {10.3389/fgstr.2025.1637172}
}
EUVIMED